Stockreport
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study [Yahoo! Finance]
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
complex human diseases and traits, including those related to blood pressure and cholesterol Results demonstrate the advantages of WGS over WES and genotyping arrays for assessing genetic risk and identifying drug target candidates. SAN DIEGO Nov. 12, 2025 /PRNewswire/ -- A study published today in Nature , authored by Illumina, Inc. (NASDAQ: ILMN) scientists and by collaborators from The University of Queensland demonstrates the importance of whole-genome sequencing (WGS) to more fully capture the genetics underlying complex human traits and diseases. Across all 34 diseases and traits studied, WGS captured nearly 90% of the genetic signal, based on heritability estimates from family studies. This marks a step toward solving the "missing heritability" problem, resolving the gap between family-based heritability and the heritability estimates made by genome wide association studies. Whole-genome sequencing uncovered insights missed by other common methods, like whole-exome sequen
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | ILMN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ILMN alerts
ILMN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
NEWS
NEWS
- Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.[MarketBeat]
- Illumina (NASDAQ:ILMN) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "sell (d+)" rating to a "hold (c-)" rating.[MarketBeat]
- Preimplantation Genetic Testing Market Size to Reach USD 1849.38 Million by 2032 – SNS Insider [Yahoo! Finance][Yahoo! Finance]
- Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study[PR Newswire]
- Illumina To Webcast Upcoming Investor Conference[PR Newswire]
- More
ILMN
SEC Filings
SEC Filings
- 11/25/25 - Form 8-K
- 11/13/25 - Form SCHEDULE
- 11/12/25 - Form 8-K
- ILMN's page on the SEC website
- More